首页 > 最新文献

Patologiya krovoobrashcheniya i kardiokhirurgiya最新文献

英文 中文
Renal cell-cancer with thrombosis in the inferior vena cava: Nephrectomy with thrombectomy 下腔静脉血栓形成的肾细胞癌:肾切除术合并血栓切除术
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-91
I. A. Zhabinets, A. M. Goritsky, I. A. Ostaltsev, S. Krasilnikov
Background. In 5–10% of cases, renal cell-cancer is complicated by the formation of a tumor thrombus in the inferior vena cava, which requires surgical intervention of nephrectomy with thrombectomy, which is essentially the only method of treatment for this category of patients. This operation is associated with technical difficulties and with the risk of intra- and postoperative complications.Aim. To retrospectively analyze the results of surgical treatment of patients who underwent nephrectomy with inferior vena cava thrombectomy. To present a case from the clinical practice of the oncology department, share experience and demonstrate the results of successful surgical treatment of renal cell-cancer.Methods. Retrospective analysis of 28 case histories of patients who underwent nephrectomy with inferior vena cava thrombectomy in the Oncology Department of the Meshalkin National Medical Research Center since 2014.Results. 28 case histories were analyzed from 2014, the average age of patients was 59 years (min 48, max 83), the dominant histological form was renal cell-cancer in 26 cases (92,8%) and nephroblastoma in 2 cases (7,2%). Complications developed in 2 (7,2%) clinical cases in the form of intraoperative bleeding, one of which turned out to be fatal. In 2022, the laparoscopic technique was implemented into clinical practice (4 operations were performed).Clinical case. Patient S., 57 years old, was hospitalized at the Meshalkin National Medical Research Center to the Department of Oncology. According to MSCT data — the formation of the right kidney with invasion into the adipose capsule, a thrombus of the renal vein with prolapse in the inferior vena cava up to 1 cm. Diagnosis — Tumor of the right kidney, tumor thrombus of the renal and inferior vena cava, T3bNxMx. The patient underwent nephrectomy of the right kidney with thrombectomy of the thrombus from the inferior vena cava. According to the results of pathohistological conclusion — renal cell-cancer of the right kidney G2 with invasion into adipose tissue, germination into the renal vein, T3bN0M0. The postoperative period passed without complications, the drainage was removed on the 2nd day, the patient was discharged on the 4th day in a satisfactory condition.Conclusion. Surgical treatment of renal cell-cancer complicated by tumor thrombosis is advisable to be carried out in multidisciplinary hospitals. Although venous invasion worsens the prognosis, a radically performed surgery gives a chance to increase life expectancy. An individualized approach to treatment planning, as well as non-standard surgical tactics involving an oncourologist and a cardiovascular surgeon in the team, allow you to carry out a full-fledged treatment, including with laparoscopic access, avoiding potentially fatal complications.
背景。在5-10%的病例中,肾细胞癌并发下腔静脉形成肿瘤血栓,这需要手术干预,即肾切除术加取栓,这基本上是这类患者的唯一治疗方法。该手术具有技术上的困难和术中及术后并发症的风险。回顾性分析行肾切除术合并下腔静脉取栓术患者的手术治疗结果。结合肿瘤内科的临床实践,总结总结肾细胞癌手术治疗的成功经验和效果。回顾性分析2014年以来Meshalkin国家医学研究中心肿瘤科28例肾切除术合并下腔静脉取栓患者的病史。分析2014年以来病例28例,平均年龄59岁(最小48岁,最大83岁),主要组织学形式为肾细胞癌26例(92,8%),肾母细胞瘤2例(7,2%)。2例(7.2%)临床病例出现并发症,表现为术中出血,其中1例死亡。2022年,腹腔镜技术应用于临床(4例手术)。临床病例。患者S, 57岁,在Meshalkin国家医学研究中心肿瘤科住院。根据MSCT数据-右肾形成并侵入脂肪囊,肾静脉血栓,下腔静脉脱垂达1cm。诊断-右肾肿瘤,肾及下腔静脉肿瘤血栓,T3bNxMx。患者行右肾切除术并从下腔静脉取栓。根据病理组织学结论-右肾肾细胞癌G2伴浸润脂肪组织,萌发入肾静脉,T3bN0M0。术后无并发症,第2天拔除引流管,第4天顺利出院。肾细胞癌合并肿瘤血栓形成的手术治疗宜在多学科医院进行。虽然静脉侵入会使预后恶化,但进行彻底的手术有机会延长预期寿命。个性化的治疗方案,以及非标准的手术策略,包括团队中的肿瘤科医生和心血管外科医生,允许您进行全面的治疗,包括腹腔镜检查,避免潜在的致命并发症。
{"title":"Renal cell-cancer with thrombosis in the inferior vena cava: Nephrectomy with thrombectomy","authors":"I. A. Zhabinets, A. M. Goritsky, I. A. Ostaltsev, S. Krasilnikov","doi":"10.21688/1681-3472-2022-2-91","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-91","url":null,"abstract":"Background. In 5–10% of cases, renal cell-cancer is complicated by the formation of a tumor thrombus in the inferior vena cava, which requires surgical intervention of nephrectomy with thrombectomy, which is essentially the only method of treatment for this category of patients. This operation is associated with technical difficulties and with the risk of intra- and postoperative complications.Aim. To retrospectively analyze the results of surgical treatment of patients who underwent nephrectomy with inferior vena cava thrombectomy. To present a case from the clinical practice of the oncology department, share experience and demonstrate the results of successful surgical treatment of renal cell-cancer.Methods. Retrospective analysis of 28 case histories of patients who underwent nephrectomy with inferior vena cava thrombectomy in the Oncology Department of the Meshalkin National Medical Research Center since 2014.Results. 28 case histories were analyzed from 2014, the average age of patients was 59 years (min 48, max 83), the dominant histological form was renal cell-cancer in 26 cases (92,8%) and nephroblastoma in 2 cases (7,2%). Complications developed in 2 (7,2%) clinical cases in the form of intraoperative bleeding, one of which turned out to be fatal. In 2022, the laparoscopic technique was implemented into clinical practice (4 operations were performed).Clinical case. Patient S., 57 years old, was hospitalized at the Meshalkin National Medical Research Center to the Department of Oncology. According to MSCT data — the formation of the right kidney with invasion into the adipose capsule, a thrombus of the renal vein with prolapse in the inferior vena cava up to 1 cm. Diagnosis — Tumor of the right kidney, tumor thrombus of the renal and inferior vena cava, T3bNxMx. The patient underwent nephrectomy of the right kidney with thrombectomy of the thrombus from the inferior vena cava. According to the results of pathohistological conclusion — renal cell-cancer of the right kidney G2 with invasion into adipose tissue, germination into the renal vein, T3bN0M0. The postoperative period passed without complications, the drainage was removed on the 2nd day, the patient was discharged on the 4th day in a satisfactory condition.Conclusion. Surgical treatment of renal cell-cancer complicated by tumor thrombosis is advisable to be carried out in multidisciplinary hospitals. Although venous invasion worsens the prognosis, a radically performed surgery gives a chance to increase life expectancy. An individualized approach to treatment planning, as well as non-standard surgical tactics involving an oncourologist and a cardiovascular surgeon in the team, allow you to carry out a full-fledged treatment, including with laparoscopic access, avoiding potentially fatal complications.","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"345 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74250971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Many years of experience in the treatment of recurrent cervical cancer 多年治疗复发性宫颈癌的经验
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-85
A. O. Shumeikina, E. A. Samoylova, K. V. Vavilov, S. Krasilnikov, N. M. Pasman
Background. The incidence of cervical cancer (CC) in the world is 500,000 new cases per year. In the structure of mortality from malignant neoplasms in women under 45 years of age, CC ranks 1st. Aim. To conduct a multivariate analysis of CC relapses, taking into account the results of primary treatment of CC patients for the subsequent choice of treatment methods for CC recurrences.Methods. Retrospective analysis of 105 case histories of patients for the period 2011–2021 who were treated at the Meshalkin National Medical Research Center and received therapy for recurrences of CC. Results. Stage I — 19 (18.1%), II — 32 (30.5%), III — 50 (47.6%), IV — 4 (3.8%). Primary methods of treatment: combined radiotherapy — 51 (49%), surgical method — 18 (17%), chemoradiotherapy — 18 (17%), surgery in combination with adjuvant radiotherapy — 15 (14%), polychemotherapy (with palliative purpose) — 1 (1%). In the structure of types of relapses: locoregional relapses — 42 (39%), local relapses — 31 (29%), metastatic hematogenous — 22 (20%), metastatic lymphogenous — 13 (12%). Late relapses (more than 12 months) — 65 (62%), early (6–12 months) — 22 (21%), progression (up to 6 months) — 18 (17%). Localizations for the occurrence of distant cervical cancer metastases: bones — 11 (39.3%), lungs — 10 (35.7%), brain — 3 (10.7%), liver — 4 (14.3%), lymphogenous metastases: supraclavicular lymph nodes — 5 (35.7%), inguinal lymph nodes — 8 (57.1%), abdominal lymph nodes — 1 (7.2%).Conclusion. In 62% there were late relapses, in 48% — in patients with initial stages, more frequent and longer follow-up with an oncogynecologist is indicated. Patients need treatment by an oncologist, radiologist, neurosurgeon, chemotherapist regardless of the stage, timing of occurrence, localization of relapses.
背景。宫颈癌(CC)在世界范围内的发病率为每年50万新病例。在45岁以下妇女因恶性肿瘤死亡的结构中,CC排名第一。的目标。对CC复发进行多因素分析,考虑CC患者的初次治疗结果,为后续CC复发的治疗方法选择提供依据。回顾性分析2011-2021年期间在Meshalkin国家医学研究中心接受CC复发治疗的105例患者的病史。阶段I - 19(18.1%)、2 - 32 (30.5%),3 - 50 (47.6%),IV - 4(3.8%)。主要治疗方法:联合放疗51例(49%),手术18例(17%),放化疗18例(17%),手术联合辅助放疗15例(14%),多重化疗(以缓解目的)1例(1%)。在复发类型的结构上:局部复发42例(39%),局部复发31例(29%),转移性血源性22例(20%),转移性淋巴源性13例(12%)。晚期复发(超过12个月)65例(62%),早期复发(6 - 12个月)22例(21%),进展(6个月)18例(17%)。宫颈癌发生远处转移的部位:骨11例(39.3%),肺10例(35.7%),脑3例(10.7%),肝4例(14.3%),淋巴转移:锁骨上淋巴结5例(35.7%),腹股沟淋巴结8例(57.1%),腹腔淋巴结1例(7.2%)。62%的患者出现晚期复发,48%的患者处于初始阶段,需要更频繁和更长时间的妇科肿瘤医生随访。患者需要由肿瘤科医生、放射科医生、神经外科医生、化疗医生进行治疗,而不论其分期、发生时间、复发部位。
{"title":"Many years of experience in the treatment of recurrent cervical cancer","authors":"A. O. Shumeikina, E. A. Samoylova, K. V. Vavilov, S. Krasilnikov, N. M. Pasman","doi":"10.21688/1681-3472-2022-2-85","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-85","url":null,"abstract":"Background. The incidence of cervical cancer (CC) in the world is 500,000 new cases per year. In the structure of mortality from malignant neoplasms in women under 45 years of age, CC ranks 1st. Aim. To conduct a multivariate analysis of CC relapses, taking into account the results of primary treatment of CC patients for the subsequent choice of treatment methods for CC recurrences.Methods. Retrospective analysis of 105 case histories of patients for the period 2011–2021 who were treated at the Meshalkin National Medical Research Center and received therapy for recurrences of CC. Results. Stage I — 19 (18.1%), II — 32 (30.5%), III — 50 (47.6%), IV — 4 (3.8%). Primary methods of treatment: combined radiotherapy — 51 (49%), surgical method — 18 (17%), chemoradiotherapy — 18 (17%), surgery in combination with adjuvant radiotherapy — 15 (14%), polychemotherapy (with palliative purpose) — 1 (1%). In the structure of types of relapses: locoregional relapses — 42 (39%), local relapses — 31 (29%), metastatic hematogenous — 22 (20%), metastatic lymphogenous — 13 (12%). Late relapses (more than 12 months) — 65 (62%), early (6–12 months) — 22 (21%), progression (up to 6 months) — 18 (17%). Localizations for the occurrence of distant cervical cancer metastases: bones — 11 (39.3%), lungs — 10 (35.7%), brain — 3 (10.7%), liver — 4 (14.3%), lymphogenous metastases: supraclavicular lymph nodes — 5 (35.7%), inguinal lymph nodes — 8 (57.1%), abdominal lymph nodes — 1 (7.2%).Conclusion. In 62% there were late relapses, in 48% — in patients with initial stages, more frequent and longer follow-up with an oncogynecologist is indicated. Patients need treatment by an oncologist, radiologist, neurosurgeon, chemotherapist regardless of the stage, timing of occurrence, localization of relapses.","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"87 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81132306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The possibilities of valve-sparing surgical treatment of bicuspid aortic valve syndrome 保留二尖瓣主动脉瓣综合征手术治疗的可能性
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-9-16
R. Komarov, V. K. Noginov
The Bentall procedure is the gold standard for the treatment of bicuspid aortic valve insufficiency, aortic root aneurysm and ascending aortic aneurysm today. Valve-sparing methods of reconstruction of the aortic root are becoming increasingly common, with the accumulation of experience in the reconstruction of the bicuspid aortic valve and more favorable hemodynamic characteristics of the native valve compared to any prosthesis. The purpose of our study is to determine the indications for surgical correction of BAV-related aortopathy and the most effective method of surgical treatment. We performed a literature review of the variants of valve-sparing surgical treatment of bicuspid aortic valve syndrome, which have shown satisfactory med-term and long-term results. The article will be interested to cardiovascular surgeons and cardiologists.Received 6 December 2021. Revised 15 February 2022. Accepted 5 March 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authors: The authors contributed equally to this article.
本特尔手术是当今治疗二尖瓣主动脉瓣不全、主动脉根部动脉瘤和升主动脉瘤的金标准。随着二尖瓣主动脉瓣重建经验的积累,以及与任何假体相比,原生瓣具有更有利的血流动力学特性,保留瓣的主动脉根重建方法正变得越来越普遍。我们研究的目的是确定手术矫正的适应症和最有效的手术治疗方法。我们对保留瓣膜的手术治疗二尖瓣主动脉瓣综合征的各种方法进行了文献回顾,这些方法显示了令人满意的中期和长期结果。这篇文章将引起心血管外科医生和心脏病专家的兴趣。收到2021年12月6日。2022年2月15日修订。2022年3月5日接受。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者的贡献:作者对本文的贡献相同。
{"title":"The possibilities of valve-sparing surgical treatment of bicuspid aortic valve syndrome","authors":"R. Komarov, V. K. Noginov","doi":"10.21688/1681-3472-2022-2-9-16","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-9-16","url":null,"abstract":"The Bentall procedure is the gold standard for the treatment of bicuspid aortic valve insufficiency, aortic root aneurysm and ascending aortic aneurysm today. Valve-sparing methods of reconstruction of the aortic root are becoming increasingly common, with the accumulation of experience in the reconstruction of the bicuspid aortic valve and more favorable hemodynamic characteristics of the native valve compared to any prosthesis. The purpose of our study is to determine the indications for surgical correction of BAV-related aortopathy and the most effective method of surgical treatment. We performed a literature review of the variants of valve-sparing surgical treatment of bicuspid aortic valve syndrome, which have shown satisfactory med-term and long-term results. The article will be interested to cardiovascular surgeons and cardiologists.Received 6 December 2021. Revised 15 February 2022. Accepted 5 March 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authors: The authors contributed equally to this article.","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75789511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The first experience of using robotic magnetic navigation for interventional treatment of post-incisional atrial flutter in patients with congenital heart defects after surgical correction: case series 应用机器人磁导航介入治疗先天性心脏缺损手术矫正后切口后心房扑动的首次经验:病例系列
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-66-72
A. Romanov, A. Filippenko, V. Beloborodov, I. Mikheenko, V. Shabanov
Post-incisional heart rhythm disturbances are one of the most frequent complications after open cardiac surgery. Lession in the atrial myocardium create conditions for slowing impulse conduction, formation and circulation of reentry. Case series included 8 patients after correction of complex congenital heart disease (CHD) with post-incisional atrial flutter (AF), despite treatment with antiarrhythmic drugs. All patients underwent interventional AF treatment using the robotic magnetic navigation (RMN) system. Perioperative complications, duration of surgery, time of fluoroscopy and efficacy (free of atrial tachyarrhythmias 3 months after the ablation procedure) of treatment were assessed during a follow-up period of 12 months.The article presents a series of clinical cases of RMN application for the treatment of post-incisional AF in patients with CHD after open cardiac surgery. The first Russian experience of using RMN for the treatment of post-incisional AF in patients with CHD after open cardiac surgery demonstrated safety and high efficiency both in the early and long-term follow-up periods. More experience and multicenter studies in a large cohort of patients are needed to determine the role of RMN as the first line of therapy for performing catheter ablation in this category of patients.Received 12 November 2021. Accepted 6 December 2021.Informed consent: The patient’s informed consent to use the records for medical purposes is obtained.Funding: The work is supported by a grant of the President of the Russian Federation No. МД-1997.2020.7Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsLiterature review: V.V. Beloborodov, A.G. FilippenkoDrafting the article: A.B. Romanov, V.V. Beloborodov, A.G. FilippenkoCritical revision of the article: A.B. Romanov, A.G. Filippenko, V.V. Beloborodov, V.V. ShabanovSurgical treatment: A.B. Romanov, V.V. ShabanovFinal approval of the version to be published: A.B. Romanov, A.G. Filippenko, V.V. Beloborodov, I.L. Mikheenko, V.V. Shabanov
切口后心律紊乱是心脏直视手术后最常见的并发症之一。心房心肌的损伤为减慢脉冲传导、形成和再入循环创造了条件。病例系列包括8例复杂先天性心脏病(CHD)手术后伴有心房扑动(AF)的患者,尽管使用抗心律失常药物治疗。所有患者均采用机器人磁导航(RMN)系统进行房颤介入治疗。随访12个月,评估围手术期并发症、手术时间、透视时间和治疗效果(消融术后3个月无房性心动过速)。本文报道了一系列应用RMN治疗冠心病心内直视手术后切口后房颤的临床病例。俄罗斯首个使用RMN治疗心内直视手术后冠心病患者切口后房颤的经验在早期和长期随访期间均显示出安全性和高效率。需要更多的经验和对大量患者的多中心研究来确定RMN作为这类患者进行导管消融的一线治疗的作用。收到2021年11月12日。2021年12月6日接受。知情同意:已取得患者知情同意将病历用于医疗目的。经费:本工作由俄罗斯联邦总统№。МД-1997.2020.7Conflict of interest:作者声明无利益冲突。作者贡献文献综述:V.V. Beloborodov, A.G. Filippenko文章起草:A.B. Romanov, V.V. Beloborodov, A.G. Filippenko文章批评修改:A.B. Romanov, A.G. Filippenko, V.V. Beloborodov, V.V. Shabanov手术治疗:A.B. Romanov, V.V. Shabanov最终批准出版版本:A.B. Romanov, A.G. Filippenko, V.V. Beloborodov, I.L. Mikheenko, V.V. Shabanov
{"title":"The first experience of using robotic magnetic navigation for interventional treatment of post-incisional atrial flutter in patients with congenital heart defects after surgical correction: case series","authors":"A. Romanov, A. Filippenko, V. Beloborodov, I. Mikheenko, V. Shabanov","doi":"10.21688/1681-3472-2022-2-66-72","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-66-72","url":null,"abstract":"Post-incisional heart rhythm disturbances are one of the most frequent complications after open cardiac surgery. Lession in the atrial myocardium create conditions for slowing impulse conduction, formation and circulation of reentry. Case series included 8 patients after correction of complex congenital heart disease (CHD) with post-incisional atrial flutter (AF), despite treatment with antiarrhythmic drugs. All patients underwent interventional AF treatment using the robotic magnetic navigation (RMN) system. Perioperative complications, duration of surgery, time of fluoroscopy and efficacy (free of atrial tachyarrhythmias 3 months after the ablation procedure) of treatment were assessed during a follow-up period of 12 months.The article presents a series of clinical cases of RMN application for the treatment of post-incisional AF in patients with CHD after open cardiac surgery. The first Russian experience of using RMN for the treatment of post-incisional AF in patients with CHD after open cardiac surgery demonstrated safety and high efficiency both in the early and long-term follow-up periods. More experience and multicenter studies in a large cohort of patients are needed to determine the role of RMN as the first line of therapy for performing catheter ablation in this category of patients.Received 12 November 2021. Accepted 6 December 2021.Informed consent: The patient’s informed consent to use the records for medical purposes is obtained.Funding: The work is supported by a grant of the President of the Russian Federation No. МД-1997.2020.7Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsLiterature review: V.V. Beloborodov, A.G. FilippenkoDrafting the article: A.B. Romanov, V.V. Beloborodov, A.G. FilippenkoCritical revision of the article: A.B. Romanov, A.G. Filippenko, V.V. Beloborodov, V.V. ShabanovSurgical treatment: A.B. Romanov, V.V. ShabanovFinal approval of the version to be published: A.B. Romanov, A.G. Filippenko, V.V. Beloborodov, I.L. Mikheenko, V.V. Shabanov","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84135054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term results of bare metal stents and frozen elephant trunk prosthesis using in aortic dissection surgery 金属支架和冷冻象鼻假体在主动脉夹层手术中的远期效果
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-89
D. Sirota, M. Zhulkov, D. Khvan, A. G. Makaev, A. Fomichev, H. Agaeva, A. Sabetov, B. Kozlov, A. Chernyavskiy
Aim. Comparative assessment of long-term results of bare metal stents and frozen elephant trunk prosthesis using in aortic dissection I DeBakey type.Methods. The retrospective comparative evaluation of different surgery results (2001–2017) in 213 patients with DeBakey type I aortic dissection was performed. Patients was divided in to 3 groups: Group 1 — standard treatment (hemiarch or total arch replacement) (n = 121), Group 2 — arch reconstruction with bare metal stent (n = 55), Group 3 — arch reconstruction with frozen elephant trunk prosthesis (n = 37). For groups equation we used propensity score matching analysis (PSM).Results. A pairwise comparison with the formation of three groups equated by the PSM method was performed. Long-term mortality in PSM 1 was 88 [82; 96] % (Group 1) и 89 [79; 100] % — (Group 2) respectively (p = 0.893). Long-term mortality in PSM 2 was 85 [71; 100] % in Group 1 and 94 [84; 100] % — Group 3 respectively (p = 0.342). Long-term mortality in PSM 3 was 88 [77; 100] % in Group 2 и 80 [64; 100] % — Group 3 respectively (p = 0.457). Freedom from aortic and mortality events (surrogate end point) in PSM 1 was 68% and 75% (p>0.999), PSM 2 was 50% and 100% (p = 0.006), PSM 3 was 73% and 89% (p = 0.22).Conclusion. There were no any statistical differences in long-term mortality and in surrogate end point (aortic events and mortality) between groups, but there was a trend to better results in Group 3.
的目标。裸金属支架与冷冻象鼻假体在主动脉夹层中的远期疗效比较对213例DeBakey I型主动脉夹层患者2001-2017年不同手术效果进行回顾性比较评价。患者分为3组:第1组-标准治疗(全弓或全弓置换)(n = 121),第2组-裸金属支架重建弓(n = 55),第3组-冷冻象鼻修复弓(n = 37)。对于群体方程,我们使用倾向得分匹配分析(PSM)。两两比较,形成三个组等价的PSM方法进行。PSM 1的长期死亡率为88 [82;96 %(第一组)89 [79;[100] % -(第二组),差异有统计学意义(p = 0.893)。PSM 2的长期死亡率为85 [71];1组100 %,94组84 %;[100] % - 3组(p = 0.342)。PSM 3的长期死亡率为88 [77;2组100 %,80例[64;[100] % - 3组(p = 0.457)。PSM 1组主动脉事件无发生率和死亡事件发生率(替代终点)分别为68%和75% (p>0.999), PSM 2组为50%和100% (p = 0.006), PSM 3组为73%和89% (p = 0.22)。两组之间的长期死亡率和替代终点(主动脉事件和死亡率)没有统计学差异,但第3组有更好的结果趋势。
{"title":"Long-term results of bare metal stents and frozen elephant trunk prosthesis using in aortic dissection surgery","authors":"D. Sirota, M. Zhulkov, D. Khvan, A. G. Makaev, A. Fomichev, H. Agaeva, A. Sabetov, B. Kozlov, A. Chernyavskiy","doi":"10.21688/1681-3472-2022-2-89","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-89","url":null,"abstract":"Aim. Comparative assessment of long-term results of bare metal stents and frozen elephant trunk prosthesis using in aortic dissection I DeBakey type.Methods. The retrospective comparative evaluation of different surgery results (2001–2017) in 213 patients with DeBakey type I aortic dissection was performed. Patients was divided in to 3 groups: Group 1 — standard treatment (hemiarch or total arch replacement) (n = 121), Group 2 — arch reconstruction with bare metal stent (n = 55), Group 3 — arch reconstruction with frozen elephant trunk prosthesis (n = 37). For groups equation we used propensity score matching analysis (PSM).Results. A pairwise comparison with the formation of three groups equated by the PSM method was performed. Long-term mortality in PSM 1 was 88 [82; 96] % (Group 1) и 89 [79; 100] % — (Group 2) respectively (p = 0.893). Long-term mortality in PSM 2 was 85 [71; 100] % in Group 1 and 94 [84; 100] % — Group 3 respectively (p = 0.342). Long-term mortality in PSM 3 was 88 [77; 100] % in Group 2 и 80 [64; 100] % — Group 3 respectively (p = 0.457). Freedom from aortic and mortality events (surrogate end point) in PSM 1 was 68% and 75% (p>0.999), PSM 2 was 50% and 100% (p = 0.006), PSM 3 was 73% and 89% (p = 0.22).Conclusion. There were no any statistical differences in long-term mortality and in surrogate end point (aortic events and mortality) between groups, but there was a trend to better results in Group 3.","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"140 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81771744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First experience of staged treatment of an infant with heterotaxy syndrome with total anomalous pulmonary vein drainage combined with a single ventricular heart and pulmonary atresia 分阶段治疗婴儿异位综合征伴肺静脉完全异常引流合并单心室心脏和肺闭锁的首次经验
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-73-78
K. Kuatbekov, A. Mishin, A. Sepbayeva, G. Nigay, D. Kanzhigalin
The combination of monoventricular congenital heart disease with total anomalous pulmonary vein drainage and pulmonary atresia, is a rare pathology and characterized by an extremely severe course with the highest mortality. In the presented work we described a clinical case of the first and successful experience of two-stage treatment of an infant with total anomalous pulmonary vein drainage combined with single ventricular heart disease and pulmonary atresia in the Republic of Kazakhstan. For total anomalous pulmonary vein drainage correction we used a sutureless technique — primary sutureless repair, which is used in our center as a primary one. Due to severe anatomy of the defect, we used unusual area of the distal end of the central systemic-pulmonary artery anastomoses during primary surgery at the mouth of the severed patent ductus arteriosus in the area of pulmonary artery bifurcation, where it is associated with high surgical risks. Taking into account the presence of an additional obstacle to pulmonary blood flow in the form of left branch pulmonary artery orifice stenosis, we performed one-stage dilatation plasty of the pulmonary artery branch bifurcation with autopericardium. During the repeated surgery we faced such a serious complication as aortic damage for the first time, thanks to emergency actions it did not turn out to be fatal. We also managed to perform the most preferable dilation of hypoplastic branches of the pulmonary artery by plasty with the own tissues of the superior vena cava during the formation of Glenn-anastomosis.Received 29 November 2021. Revised 21 December 2021. Accepted 22 December 2021.Informed consent: Informed consent was obtained from the patient's mother for the publication and use of the patient's medical data for scientific purposes.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsLiterature review: A.V. MishinDrafting the article: A.V. MishinCritical revision of the article: K.N. Kuatbekov, A.D. SepbayevaSurgical treatment: K.N. Kuatbekov, A.V. Mishin, A.D. Sepbayeva, G.S. Nigay, D.M. KanzhigalinFinal approval of the version to be published: K.N. Kuatbekov, A.V. Mishin, A.D. Sepbayeva, G.S. Nigay, D.M. Kanzhigalin
单室先天性心脏病合并肺静脉完全异常引流和肺闭锁是一种罕见的病理,其特点是病程极其严重,死亡率最高。在提出的工作中,我们描述了一个临床病例的第一个和成功的经验两阶段治疗的婴儿完全异常肺静脉引流合并单室心脏病和肺闭锁在哈萨克斯坦共和国。对于完全异常肺静脉引流矫正,我们使用无缝线技术-初级无缝线修复,这是我们中心使用的主要技术。由于严重的解剖缺陷,我们在原发性手术中在肺动脉分叉区切断的动脉导管未闭口处使用了中央系统-肺动脉吻合处远端不寻常的区域,该区域手术风险高。考虑到肺动脉左分支口狭窄对肺血流的额外障碍,我们对肺动脉分支进行了一期心包自闭扩张成形术。在反复的手术过程中,我们第一次遇到了严重的并发症,如主动脉损伤,幸亏采取了紧急措施,没有致命的危险。在格伦吻合形成的过程中,我们还利用上腔静脉自身组织进行了最理想的肺动脉发育不全分支扩张。收到2021年11月29日。2021年12月21日修订。2021年12月22日接受。知情同意:为科学目的出版和使用患者的医疗数据已获得患者母亲的知情同意。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者贡献文献综述:A.V. Mishin文章起草:A.V. Mishin文章关键性修改:K.N. Kuatbekov, A.D. Sepbayeva手术治疗:K.N. Kuatbekov, A.V. Mishin, A.D. Sepbayeva, G.S. Nigay, D.M. Kanzhigalin最终审定版本:K.N. Kuatbekov, A.V. Mishin, A.D. Sepbayeva, G.S. Nigay, D.M. Kanzhigalin
{"title":"First experience of staged treatment of an infant with heterotaxy syndrome with total anomalous pulmonary vein drainage combined with a single ventricular heart and pulmonary atresia","authors":"K. Kuatbekov, A. Mishin, A. Sepbayeva, G. Nigay, D. Kanzhigalin","doi":"10.21688/1681-3472-2022-2-73-78","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-73-78","url":null,"abstract":"The combination of monoventricular congenital heart disease with total anomalous pulmonary vein drainage and pulmonary atresia, is a rare pathology and characterized by an extremely severe course with the highest mortality. In the presented work we described a clinical case of the first and successful experience of two-stage treatment of an infant with total anomalous pulmonary vein drainage combined with single ventricular heart disease and pulmonary atresia in the Republic of Kazakhstan. For total anomalous pulmonary vein drainage correction we used a sutureless technique — primary sutureless repair, which is used in our center as a primary one. Due to severe anatomy of the defect, we used unusual area of the distal end of the central systemic-pulmonary artery anastomoses during primary surgery at the mouth of the severed patent ductus arteriosus in the area of pulmonary artery bifurcation, where it is associated with high surgical risks. Taking into account the presence of an additional obstacle to pulmonary blood flow in the form of left branch pulmonary artery orifice stenosis, we performed one-stage dilatation plasty of the pulmonary artery branch bifurcation with autopericardium. During the repeated surgery we faced such a serious complication as aortic damage for the first time, thanks to emergency actions it did not turn out to be fatal. We also managed to perform the most preferable dilation of hypoplastic branches of the pulmonary artery by plasty with the own tissues of the superior vena cava during the formation of Glenn-anastomosis.Received 29 November 2021. Revised 21 December 2021. Accepted 22 December 2021.Informed consent: Informed consent was obtained from the patient's mother for the publication and use of the patient's medical data for scientific purposes.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsLiterature review: A.V. MishinDrafting the article: A.V. MishinCritical revision of the article: K.N. Kuatbekov, A.D. SepbayevaSurgical treatment: K.N. Kuatbekov, A.V. Mishin, A.D. Sepbayeva, G.S. Nigay, D.M. KanzhigalinFinal approval of the version to be published: K.N. Kuatbekov, A.V. Mishin, A.D. Sepbayeva, G.S. Nigay, D.M. Kanzhigalin","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"108 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73431974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wrapping of the ascending aorta: history and prospects 升主动脉包裹术:历史与前景
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-30-37
V. Akulov, S. Alsov, D. Sirota, M. Lyashenko, A. Chernyavskiy
Historically, exoprosthetics is one of the first surgical procedures used for aneurysmal dilatation of such great vessels as the aorta. Despite the acceptable results of this method it is not widespread now because of the possible negative consequences of aortic wall wrapping (rupture or dissection).According to the latest guidelines, it is necessary to consider prosthetics of the ascending aorta by the patients with aortic valve surgery and aneurysmal dilatation of the ascending aorta more than 45 mm. However, early postoperative mortality reaches 20 % by elderly patients with severe comorbidities. In such situations, it is worth to choose a less traumatic surgical approach. Exoprosthetics of the aorta reduces the invasiveness of procedure, time of artificial circulation and aortic occlusion thereby taking down the risks of early postoperative complications.The purpose of this literature review is to analyze the current data on the technique of exoprosthetics of the aorta by the patients with moderate ascending aorta dilatation. The Scopus, Web of Science, PubMed databases were used for searching and selecting literature sources.The results demonstrate that aortic wrapping is a safe method causing rapid and permanent aortic remodeling. The technique has comparable long-term results with prosthetics of the ascending aorta despite the presence of histological changes in the aortic wall with a changing in its mechanical properties.Received 28 September 2021. Revised 19 January 2022. Accepted 20 January 2022.Funding: This work was carried out within the framework of the state task of Ministry of Health of Russian Federation No. 121032300337-5.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsConception and study design: S.A. Alsov, D.A. SirotaDrafting the article: V.A. AkulovCritical revision of the article: S.A. Alsov, D.A. Sirota, M.M. Lyashenko, A.M. ChernyavskiyFinal approval of the version to be published: V.A. Akulov, S.A. Alsov, D.A. Sirota, M.M. Lyashenko, A.M. Chernyavskiy
从历史上看,外植体是最早用于主动脉等大血管动脉瘤扩张的外科手术之一。尽管这种方法的结果是可以接受的,但由于主动脉壁包裹可能产生的不良后果(破裂或剥离),这种方法现在并不普遍。根据最新的指南,主动脉瓣手术和升主动脉动脉瘤扩张超过45mm的患者有必要考虑升主动脉修复术。然而,伴有严重合并症的老年患者术后早期死亡率可达20%。在这种情况下,选择创伤较小的手术方法是值得的。主动脉外植体减少了手术的侵入性、人工循环时间和主动脉阻塞,降低了术后早期并发症的风险。本文旨在分析目前有关中度升主动脉扩张患者主动脉外植体技术的资料。使用Scopus、Web of Science、PubMed等数据库进行文献检索和选择。结果表明,主动脉包裹术是一种安全的方法,可引起快速和永久性的主动脉重塑。尽管主动脉壁存在组织学变化,其机械性能也发生了变化,但该技术与升主动脉假体的长期效果相当。收到2021年9月28日。2022年1月19日修订。接受2022年1月20日。资助:这项工作是在俄罗斯联邦卫生部第121032300337-5号国家任务的框架内进行的。利益冲突:作者声明无利益冲突。作者贡献:构思和研究设计:S.A. Alsov, D.A. sirot文章起草:V.A. akulov文章关键修改:S.A. Alsov, D.A. Sirota, M.M. Lyashenko, A.M.车尔尼雅夫斯基最终批准出版的版本:V.A.阿库洛夫,S.A.阿索夫,D.A.西罗塔,M.M.利亚申科,A.M.Chernyavskiy
{"title":"Wrapping of the ascending aorta: history and prospects","authors":"V. Akulov, S. Alsov, D. Sirota, M. Lyashenko, A. Chernyavskiy","doi":"10.21688/1681-3472-2022-2-30-37","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-30-37","url":null,"abstract":"Historically, exoprosthetics is one of the first surgical procedures used for aneurysmal dilatation of such great vessels as the aorta. Despite the acceptable results of this method it is not widespread now because of the possible negative consequences of aortic wall wrapping (rupture or dissection).According to the latest guidelines, it is necessary to consider prosthetics of the ascending aorta by the patients with aortic valve surgery and aneurysmal dilatation of the ascending aorta more than 45 mm. However, early postoperative mortality reaches 20 % by elderly patients with severe comorbidities. In such situations, it is worth to choose a less traumatic surgical approach. Exoprosthetics of the aorta reduces the invasiveness of procedure, time of artificial circulation and aortic occlusion thereby taking down the risks of early postoperative complications.The purpose of this literature review is to analyze the current data on the technique of exoprosthetics of the aorta by the patients with moderate ascending aorta dilatation. The Scopus, Web of Science, PubMed databases were used for searching and selecting literature sources.The results demonstrate that aortic wrapping is a safe method causing rapid and permanent aortic remodeling. The technique has comparable long-term results with prosthetics of the ascending aorta despite the presence of histological changes in the aortic wall with a changing in its mechanical properties.Received 28 September 2021. Revised 19 January 2022. Accepted 20 January 2022.Funding: This work was carried out within the framework of the state task of Ministry of Health of Russian Federation No. 121032300337-5.Conflict of interest: Authors declare no conflict of interest.Contribution of the authorsConception and study design: S.A. Alsov, D.A. SirotaDrafting the article: V.A. AkulovCritical revision of the article: S.A. Alsov, D.A. Sirota, M.M. Lyashenko, A.M. ChernyavskiyFinal approval of the version to be published: V.A. Akulov, S.A. Alsov, D.A. Sirota, M.M. Lyashenko, A.M. Chernyavskiy","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74362426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-frequency spinal cord stimulation in treatment of chronic limb-threatening ischemia (HEAL-SCS): short-term results of a randomized trial 高频脊髓刺激治疗慢性肢体威胁缺血(heals - scs):一项随机试验的短期结果
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-87
M. Kilchukov, R. Kiselev, V. Murtazin, K. Orlov
Background. Critical limb ischemia is defined as persistent ischemic pain attributed to a variety of severely compromised blood flow to affected extremities. The treatment of non-reconstructable critical limb ischemia is still challenging; the amputation rate was 9.3%, and mortality rate was 23.2% within 24 months. Spinal cord stimulation (SCS) has become an alternative clinical practice for the treatment of intractable pain of the extremities.Aim. To determine whether high-frequency spinal cord stimulation (SCS) is better than low-frequency SCS for pain relief in chronic limb-threatening ischemia treatment.Methods. Throughout enrollment 56 patients were examined, of whom 6 rejected to participate in the study. The participants were randomly allocated to high-frequency (HF) or low frequency (LF)-SCS groups of 25 patients each by an external statistician, using an online tool. The patients were examined by a neurosurgeon and a vascular surgeon to assess pain intensity by visual analog scale, quality of life by short-form-36 health survey (SF-36), and functional status by walking impairment questionnaire in 3 and 12 months. Tissue perfusion by transcutaneous oxygen tension measurement was also measured in 12 months.Results. Intention-to-treat analysis demonstrated comparative advantage of HF-SCS over LF-SCS in 3 months with mean visual analog scale score 2.8 [95% CI, 2.4; 3.2] and 3.3 [95% CI, 3.0; 3.6] respectively (p = 0.031). Clinical superiority of HF-SCS persisted at 12 months follow up (p<0.001). HF-SCS produces significantly greater pain relief by walking impairment questionnaire in 3 (p<0.001) and 12 months (p = 0.009). Accordingly, general and mental health domains of SF-36 were significantly better in HF-SCS in 12 months. Despite a tendency toward better resting oxygen pressure in HF-SCS group, there was no intergroup difference by transcutaneous oxygen tension (p = 0.076).Conclusion. High-frequency spinal cord stimulation imposes better pain relief, life quality and functional activity in patients with chronic limb-threatening ischemia in short-term follow up.
背景。临界肢体缺血被定义为由于各种严重受损的血流到受影响的肢体的持续缺血性疼痛。不可重建的危重肢体缺血的治疗仍然具有挑战性;截肢率为9.3%,24个月内死亡率为23.2%。脊髓刺激(SCS)已成为治疗顽固性四肢疼痛的一种替代临床实践。目的:探讨高频脊髓刺激(SCS)在慢性肢体缺血治疗中的镇痛效果是否优于低频脊髓刺激(SCS)。在整个入组过程中,对56例患者进行了检查,其中6例拒绝参加研究。由外部统计学家使用在线工具将参与者随机分配到高频(HF)或低频(LF)-SCS组,每组25例患者。分别由神经外科医生和血管外科医生分别于3个月和12个月对患者进行视觉模拟量表评估疼痛强度、SF-36生活质量和步行功能障碍问卷调查。经皮氧张力法测定12个月后组织灌注情况。意向治疗分析显示,在3个月内,HF-SCS优于LF-SCS,平均视觉模拟量表评分为2.8 [95% CI, 2.4;3.2]和3.3 [95% CI, 3.0;3.6], p = 0.031。在12个月的随访中,HF-SCS的临床优势持续存在(p<0.001)。通过3个月(p<0.001)和12个月(p = 0.009)的步行障碍问卷调查,HF-SCS对疼痛的缓解效果显著。相应的,SF-36的一般和心理健康领域在12个月内显著改善。尽管HF-SCS组有较好的静息氧压的趋势,但经皮氧张力组间无差异(p = 0.076)。在短期随访中,高频脊髓刺激对慢性肢体缺血患者的疼痛缓解、生活质量和功能活动有较好的效果。
{"title":"High-frequency spinal cord stimulation in treatment of chronic limb-threatening ischemia (HEAL-SCS): short-term results of a randomized trial","authors":"M. Kilchukov, R. Kiselev, V. Murtazin, K. Orlov","doi":"10.21688/1681-3472-2022-2-87","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-87","url":null,"abstract":"Background. Critical limb ischemia is defined as persistent ischemic pain attributed to a variety of severely compromised blood flow to affected extremities. The treatment of non-reconstructable critical limb ischemia is still challenging; the amputation rate was 9.3%, and mortality rate was 23.2% within 24 months. Spinal cord stimulation (SCS) has become an alternative clinical practice for the treatment of intractable pain of the extremities.Aim. To determine whether high-frequency spinal cord stimulation (SCS) is better than low-frequency SCS for pain relief in chronic limb-threatening ischemia treatment.Methods. Throughout enrollment 56 patients were examined, of whom 6 rejected to participate in the study. The participants were randomly allocated to high-frequency (HF) or low frequency (LF)-SCS groups of 25 patients each by an external statistician, using an online tool. The patients were examined by a neurosurgeon and a vascular surgeon to assess pain intensity by visual analog scale, quality of life by short-form-36 health survey (SF-36), and functional status by walking impairment questionnaire in 3 and 12 months. Tissue perfusion by transcutaneous oxygen tension measurement was also measured in 12 months.Results. Intention-to-treat analysis demonstrated comparative advantage of HF-SCS over LF-SCS in 3 months with mean visual analog scale score 2.8 [95% CI, 2.4; 3.2] and 3.3 [95% CI, 3.0; 3.6] respectively (p = 0.031). Clinical superiority of HF-SCS persisted at 12 months follow up (p<0.001). HF-SCS produces significantly greater pain relief by walking impairment questionnaire in 3 (p<0.001) and 12 months (p = 0.009). Accordingly, general and mental health domains of SF-36 were significantly better in HF-SCS in 12 months. Despite a tendency toward better resting oxygen pressure in HF-SCS group, there was no intergroup difference by transcutaneous oxygen tension (p = 0.076).Conclusion. High-frequency spinal cord stimulation imposes better pain relief, life quality and functional activity in patients with chronic limb-threatening ischemia in short-term follow up.","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82097950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The choice of echocardiographic parameters for determining the hemodynamics phenotype in children after Fontan procedure 选择超声心动图参数确定Fontan手术后儿童血流动力学表型
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-38-48
Y. Sinelnikov, E. N. Orekhova, S. A. Orekhov, T. V. Matanovskaya
Aim. Evaluation of echocardiographic parameters to characterize the hemodynamics phenotype in children after Fontan procedure.Methods. 30 children aged 8.06 ± 4.3 years, body surface area 0.95 ± 0.33 m2, 12 boys (40%) with a functionally single ventricle after total cavopulmonary connection with extracardiac conduit fenestration. In addition to traditional echocardiographic parameters we assessed: systemic ventricular preload (stroke volume index, SVI), ventricular afterload (arterial elastance), arterial compliance, end–systolic ventricular elastance (VE), ventricular–arterial coupling (VAC), transpulmonary gradient (TPG).Results. In 33.3% (n = 10) children, the parameters of the single ventricle function were comparable to the normative values in biventricular hemodynamics. In 3 (10%) patients decreased values of the single ventricle systolic function were found (ejection fraction 40.0 ± 3.5%, fraction area changes 44.6 ± 3.5%, longitudinal strain −4.03 ± 0.87%), preload (SVI 13.30 ± 0.64 ml/m2), arterial compliance, (0.47 ± 0.17 ml/mm Hg), increased VAC (1.81 ± 0.10). In 36.6% of children (n = 11), a decrease in preload was found (SVI 27.4 ± 1.2 ml/m2), an increase in ventricular-arterial coupling (2.17 ± 0.16), and a decrease VE (1.98 ± 0.45 mm Hg/ml), an increase E/e´ (13.2 ± 1.7). In 20% of cases (n = 6) an increase in TPG was determined (11.6 ± 0.9 mm Hg).Conclusion. In children after Fontan procedure, 4 hemodynamic phenotypes were revealed in accordance with echocardiographic parameters: compensated, hypocontractile, with impaired diastolic properties of the systemic ventricle and with increased pulmonary vascular resistance. With a hypocontractile phenotype of hemodynamics, a significantly increased concentration of the pro-brain natriuretic peptide is determined. The phenotype of hemodynamics with increased pulmonary vascular resistance is more often associated with a higher functional class of heart failure.Received 10 September 2021. Revised 4 October 2022. Accepted 14 December 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authors: The authors contributed equally to this article.
的目标。评价超声心动图参数表征Fontan手术后儿童血流动力学表型。儿童30例,年龄8.06±4.3岁,体表面积0.95±0.33 m2,男孩12例(40%),经全腔室肺连接心外导管开窗后功能单一脑室。除了传统的超声心动图参数外,我们还评估了:全身心室前负荷(脑卒中容积指数,SVI)、心室后负荷(动脉弹性)、动脉顺应性、收缩末期心室弹性(VE)、心室-动脉耦合(VAC)、跨肺梯度(TPG)。在33.3% (n = 10)的儿童中,单心室功能参数与双心室血流动力学正常值相当。3例(10%)患者单心室收缩功能下降(射血分数40.0±3.5%,分数面积变化44.6±3.5%,纵向应变- 4.03±0.87%),预负荷(SVI 13.30±0.64 ml/m2),动脉顺应性(0.47±0.17 ml/mm Hg), VAC升高(1.81±0.10)。36.6%的患儿(n = 11)的预负荷降低(SVI 27.4±1.2 ml/m2),脑室-动脉耦合增加(2.17±0.16),VE降低(1.98±0.45 mm Hg/ml), E/ E′增加(13.2±1.7)。20%的病例(n = 6)检测到TPG升高(11.6±0.9 mm Hg)。在Fontan手术后的儿童中,根据超声心动图参数显示出4种血流动力学表型:代偿性、低收缩性、全身心室舒张特性受损和肺血管阻力增加。随着血流动力学的低收缩表型,确定了前脑利钠肽的浓度显著增加。肺血管阻力增加的血流动力学表型更常与更高功能级别的心力衰竭相关。收到2021年9月10日。2022年10月4日修订。接受于2022年12月14日。经费来源:本研究未获得赞助。利益冲突:作者声明无利益冲突。作者的贡献:作者对本文的贡献相同。
{"title":"The choice of echocardiographic parameters for determining the hemodynamics phenotype in children after Fontan procedure","authors":"Y. Sinelnikov, E. N. Orekhova, S. A. Orekhov, T. V. Matanovskaya","doi":"10.21688/1681-3472-2022-2-38-48","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-38-48","url":null,"abstract":"Aim. Evaluation of echocardiographic parameters to characterize the hemodynamics phenotype in children after Fontan procedure.Methods. 30 children aged 8.06 ± 4.3 years, body surface area 0.95 ± 0.33 m2, 12 boys (40%) with a functionally single ventricle after total cavopulmonary connection with extracardiac conduit fenestration. In addition to traditional echocardiographic parameters we assessed: systemic ventricular preload (stroke volume index, SVI), ventricular afterload (arterial elastance), arterial compliance, end–systolic ventricular elastance (VE), ventricular–arterial coupling (VAC), transpulmonary gradient (TPG).Results. In 33.3% (n = 10) children, the parameters of the single ventricle function were comparable to the normative values in biventricular hemodynamics. In 3 (10%) patients decreased values of the single ventricle systolic function were found (ejection fraction 40.0 ± 3.5%, fraction area changes 44.6 ± 3.5%, longitudinal strain −4.03 ± 0.87%), preload (SVI 13.30 ± 0.64 ml/m2), arterial compliance, (0.47 ± 0.17 ml/mm Hg), increased VAC (1.81 ± 0.10). In 36.6% of children (n = 11), a decrease in preload was found (SVI 27.4 ± 1.2 ml/m2), an increase in ventricular-arterial coupling (2.17 ± 0.16), and a decrease VE (1.98 ± 0.45 mm Hg/ml), an increase E/e´ (13.2 ± 1.7). In 20% of cases (n = 6) an increase in TPG was determined (11.6 ± 0.9 mm Hg).Conclusion. In children after Fontan procedure, 4 hemodynamic phenotypes were revealed in accordance with echocardiographic parameters: compensated, hypocontractile, with impaired diastolic properties of the systemic ventricle and with increased pulmonary vascular resistance. With a hypocontractile phenotype of hemodynamics, a significantly increased concentration of the pro-brain natriuretic peptide is determined. The phenotype of hemodynamics with increased pulmonary vascular resistance is more often associated with a higher functional class of heart failure.Received 10 September 2021. Revised 4 October 2022. Accepted 14 December 2022.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Contribution of the authors: The authors contributed equally to this article.","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86195242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of X-ray endovascular occlusion methods in the treatment of prostate cancer x线血管内闭塞技术在前列腺癌治疗中的应用
Q4 Medicine Pub Date : 2022-06-30 DOI: 10.21688/1681-3472-2022-2-88
A. M. Goritsky, I. A. Zhabinets, I. A. Ostaltsev, O. Pashkovskaya, T. G. Vorobyeva, O. Krestyaninov, S. Krasilnikov
Background. The use of radiotherapy at the treatment of prostate cancer makes it possible to radically cure the neoplasm, but does not reduce infravesical obstruction. With localized prostate cancer, the cause of acute urinary retention is concomitant benign prostatic hyperplasia. X-ray endovascular occlusion of the prostate vessels is based on a decrease in arterial inflow to the prostate gland, which leads to a decrease in its volume and a decrease in the severity of symptoms of obstruction.Aim. To evaluate the effectiveness of the use of X-ray endovascular occlusion of the prostate vessels as a combined treatment for prostate cancer in order to reduce infravesical obstruction.Methods. 15 patients with severe lower urinary tract symptoms scheduled for RT for prostate cancer. Average age is 68 years. Inclusion criteria: Qmax <10 ml/sec, prostate volume >50 cm3, residual urine volume >50 ml. In the conditions of the X-ray operating room, a puncture of the common femoral artery was performed, a microcatheter was carried out to the arteries of the prostate gland and their selective embolization with microparticles with a diameter of 250–500 microns.Results. 1 patient underwent unilateral embolization, 1 patient failed to embolize the arteries on both sides, 1 patient underwent embolization after remote radiation therapy due to the development of obstruction. 2 patients with locally advanced and metastatic prostate cancer without radiotherapy. There were no complications during the treatment and in the postoperative period. All patients noted positive dynamics in assessing the quality of urination. All patients had a decrease in prostate volume and urodynamic parameters (14 to 30 days) after embolization. No significant positive dynamics was achieved in 2 patients.Conclusion. X-ray endovascular occlusion of the prostate vessels is an effective minimally invasive method, can be considered as an independent technique and used to reduce the volume of the prostate in preparation for subsequent radiotherapy. The technique expands the doctor's arsenal when choosing a method for treating prostate cancer, improves the results of treatment, and also has a positive effect on the quality of life.
背景。在前列腺癌的治疗中使用放射治疗可以从根本上治愈肿瘤,但不能减少膀胱下梗阻。对于局限性前列腺癌,急性尿潴留的原因是伴随良性前列腺增生。x线摄护腺血管内闭塞是基于流入前列腺的动脉减少,从而导致其体积减小和阻塞症状的严重程度减轻。目的探讨x线前列腺血管内闭塞术联合治疗前列腺癌的效果,以减少膀胱下梗阻。15例有严重下尿路症状的前列腺癌患者计划接受放射治疗。平均年龄为68岁。纳入标准:Qmax 50 cm3,残尿量>50 ml。在x线手术室条件下,穿刺股总动脉,在前列腺动脉内置入微导管,用直径250 ~ 500微米的微颗粒选择性栓塞。1例患者单侧动脉栓塞,1例患者双侧动脉栓塞失败,1例患者因梗阻发展在远程放疗后栓塞。局部晚期转移性前列腺癌2例,未行放疗。治疗期间及术后均无并发症发生。所有患者在评估排尿质量时均注意到积极的动态变化。所有患者在栓塞后(14 ~ 30天)前列腺体积和尿动力学参数均下降。2例患者无明显的积极动态。x线血管内封堵前列腺血管是一种有效的微创方法,可视为一种独立的技术,用于缩小前列腺体积,为后续放疗做准备。在选择治疗前列腺癌的方法时,这项技术扩大了医生的武器库,改善了治疗效果,对生活质量也有积极的影响。
{"title":"Application of X-ray endovascular occlusion methods in the treatment of prostate cancer","authors":"A. M. Goritsky, I. A. Zhabinets, I. A. Ostaltsev, O. Pashkovskaya, T. G. Vorobyeva, O. Krestyaninov, S. Krasilnikov","doi":"10.21688/1681-3472-2022-2-88","DOIUrl":"https://doi.org/10.21688/1681-3472-2022-2-88","url":null,"abstract":"Background. The use of radiotherapy at the treatment of prostate cancer makes it possible to radically cure the neoplasm, but does not reduce infravesical obstruction. With localized prostate cancer, the cause of acute urinary retention is concomitant benign prostatic hyperplasia. X-ray endovascular occlusion of the prostate vessels is based on a decrease in arterial inflow to the prostate gland, which leads to a decrease in its volume and a decrease in the severity of symptoms of obstruction.Aim. To evaluate the effectiveness of the use of X-ray endovascular occlusion of the prostate vessels as a combined treatment for prostate cancer in order to reduce infravesical obstruction.Methods. 15 patients with severe lower urinary tract symptoms scheduled for RT for prostate cancer. Average age is 68 years. Inclusion criteria: Qmax <10 ml/sec, prostate volume >50 cm3, residual urine volume >50 ml. In the conditions of the X-ray operating room, a puncture of the common femoral artery was performed, a microcatheter was carried out to the arteries of the prostate gland and their selective embolization with microparticles with a diameter of 250–500 microns.Results. 1 patient underwent unilateral embolization, 1 patient failed to embolize the arteries on both sides, 1 patient underwent embolization after remote radiation therapy due to the development of obstruction. 2 patients with locally advanced and metastatic prostate cancer without radiotherapy. There were no complications during the treatment and in the postoperative period. All patients noted positive dynamics in assessing the quality of urination. All patients had a decrease in prostate volume and urodynamic parameters (14 to 30 days) after embolization. No significant positive dynamics was achieved in 2 patients.Conclusion. X-ray endovascular occlusion of the prostate vessels is an effective minimally invasive method, can be considered as an independent technique and used to reduce the volume of the prostate in preparation for subsequent radiotherapy. The technique expands the doctor's arsenal when choosing a method for treating prostate cancer, improves the results of treatment, and also has a positive effect on the quality of life.","PeriodicalId":19853,"journal":{"name":"Patologiya krovoobrashcheniya i kardiokhirurgiya","volume":"177 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79892258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Patologiya krovoobrashcheniya i kardiokhirurgiya
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1